TS Financial Group (TSFG)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58K | Hold |
75
| – | – | 0.01% | 331 |
|
|
2025
Q4 | $58K | Sell |
75
-17
| -18% | -$11.5K | 0.01% | 315 |
|
|
2025
Q3 | $52K | Hold |
92
| – | – | 0.01% | 334 |
|
|
2025
Q2 | $48K | Buy |
92
+17
| +23% | +$9.49K | 0.01% | 335 |
|
|
2025
Q1 | $48K | Sell |
75
-15
| -17% | -$10.3K | 0.01% | 317 |
|
|
2024
Q4 | $64K | Hold |
90
| – | – | 0.01% | 265 |
|
|
2024
Q3 | $95K | Hold |
90
| – | – | 0.02% | 218 |
|
|
2024
Q2 | $95K | Hold |
90
| – | – | 0.02% | 204 |
|
|
2024
Q1 | $87K | Hold |
90
| – | – | 0.02% | 207 |
|
|
2023
Q4 | $79K | Hold |
90
| – | – | 0.02% | 231 |
|
|
2023
Q3 | $74K | Hold |
90
| – | – | 0.03% | 241 |
|
|
2023
Q2 | $65K | Hold |
90
| – | – | 0.02% | 251 |
|
|
2023
Q1 | $74K | Hold |
90
| – | – | 0.03% | 230 |
|
|
2022
Q4 | $65K | Buy |
90
+55
| +157% | +$40.6K | 0.03% | 248 |
|
|
2022
Q3 | $24K | Sell |
35
-5
| -13% | -$3.15K | 0.01% | 382 |
|
|
2022
Q2 | $24K | Hold |
40
| – | – | 0.01% | 383 |
|
|
2022
Q1 | $28K | Hold |
40
| – | – | 0.01% | 368 |
|
|
2021
Q4 | $25K | Hold |
40
| – | – | 0.01% | 393 |
|
|
2021
Q3 | $24K | Hold |
40
| – | – | 0.01% | 409 |
|
|
2021
Q2 | $22K | Hold |
40
| – | – | 0.01% | 418 |
|
|
2021
Q1 | $19K | Sell |
40
-16
| -29% | -$7.79K | 0.01% | 379 |
|
|
2020
Q4 | $27K | Sell |
56
-63
| -53% | -$34K | 0.01% | 331 |
|
|
2020
Q3 | $67K | Buy |
119
+56
| +89% | +$34K | 0.04% | 187 |
|
|
2020
Q2 | $39K | Sell |
63
-8
| -11% | -$4.54K | 0.03% | 252 |
|
|
2020
Q1 | $35K | Sell |
71
-165
| -70% | -$68.1K | 0.03% | 235 |
|
|
2019
Q4 | $89K | Buy |
236
+202
| +594% | +$68K | 0.07% | 154 |
|
|
2019
Q3 | $9K | Buy |
34
+4
| +13% | +$1.18K | 0.01% | 432 |
|
|
2019
Q2 | $9K | Buy |
30
+1
| +3% | +$333 | 0.01% | 426 |
|
|
2019
Q1 | $12K | Buy |
+29
| New | +$11.9K | 0.01% | 369 |
|
Other funds holding REGN
VCM
N